Skip to main content
OpenTrials

Clinical trial condition

Anemia, Hemolytic, Congenital

Explore clinical trials studying Anemia, Hemolytic, Congenital. Study availability and eligibility vary by location and protocol.

1,131 public trials 182 recruiting studies
Refine in advanced search Browse all conditions

Anemia, Hemolytic, Congenital trial results

Completed

Study to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell Disease

NCT04817670

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • Investigator Site 709 Birmingham, Alabama, United States
  • Investigator Site 708 Los Angeles, California, United States
  • Investigator Site 713 Aurora, Colorado, United States
  • Investigator Site 706 Hollywood, Florida, United States
View all 22 locations
View Trial Details
Completed

COVID-19 Vaccine Response in Sickle Cell Disease

NCT05139992

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +19 more
Locations
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Montefiore Hospital The Bronx, New York, United States
View Trial Details
Completed

Low Dose Aspirin for Preventing Intrauterine Growth Restriction and Preeclampsia in Sickle Cell Pregnancy (PIPSICKLE)

NCT05253781

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +19 more
Locations
  • Ajeromi General Hospital, Ajegunle, Lagos State Ajegunle, Lagos, Nigeria
  • Federal Medical Centre, Ebute Metta, Lagos State Ebute-Metta, Lagos, Nigeria
  • Lagos University Teaching Hospital Idi-Araba, Lagos, Nigeria
  • Alimosho General Hospital, Igando, Lagos State Igando, Lagos, Nigeria
View all 16 locations
View Trial Details

Related conditions